+149.2%
MRNA vs SN
+409.8%
-260.5%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | SN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.8% | +4.5% | -9.4% | -6.0% |
| 7D | -20.9% | +1.4% | -22.3% | -21.2% |
| 30D | -13.3% | +21.8% | -35.0% | -17.2% |
| 3M | +212.6% | +25.9% | +186.7% | +194.2% |
| 6M | +309.0% | +116.2% | +192.8% | +229.4% |
| YTD | +567.3% | +105.6% | +461.7% | +439.3% |
| 1Y | +689.7% | +172.1% | +517.6% | +493.1% |
| All | +149.2% | +409.8% | -260.5% | +60.3% |
Cumulative growth
Daily Returns
Daily percentage return beside SN.
Daily Out/Under-Performance
Portfolio return minus SN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded SN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling